Brokerage firm JM Financial noted that the announcement is negative for Indian companies like Aurobindo Pharma, Dr Reddys Laboratories, Lupin, Sun Pharmaceutical Industries, Zydus Lifesciences, etc.
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Leave a Comment